The faculty and staff of the Clinical Core will continue to recruit, enroll, examine and characterize patients with Alzheimer's disease (AD) and normal controls yearly in the Patient/Control Registry of the Boston University Alzheimer's Disease Center. In addition to clinical characterization, blood will be collected for the Molecular Core, and participants/family members in the Patient/Control Registry will be asked to consider brain donation for participants at the time of death for the Neuropathology Core. In addition to maintaining the current high autopsy rate among participants who die in the community. The Clinical Core will also continue to recruit family and professional caregivers into a special Caregiver Registry. With the permission of the registrants, data and participants from the Patient/Control Registry and the Caregiver Registry are made available to qualified investigators in AD and related areas in order to enhance their research success. Finally, the Clinical Core supports the mission and efforts of other Cores, particularly the Education core. In the first funding period of the BU ADC, the Clinical Core has demonstrated strengths in enrolling and utilizing late-stage AD patients in clinical research, and in reaching out to recruit participants from among the urban, underprivileged, minority communities immediately surrounding the Boston Medical Center. Productive scientific collaborations with numerous clinical and basic science investigators have resulted from the utilization of Clinical Core data. In this renewal, we propose to continue the expansion of the Clinical Core at Boston Medical Center and to build upon our recruiting and retention successes in the African American communities of Boston. We further propose to expand our affiliation with the Franmingham Heart Study in order to help collect longitudinal clinical data and pursue clinico-pathological correlations in persons who participate in this unique longitudinal, multi- generation population based study.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
3P30AG013846-07S1
Application #
6659116
Study Section
Project Start
2002-08-15
Project End
2003-06-30
Budget Start
Budget End
Support Year
7
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Boston University
Department
Type
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Alosco, Michael L; Tripodis, Yorghos; Fritts, Nathan G et al. (2018) Cerebrospinal fluid tau, A?, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration. Alzheimers Dement 14:1159-1170
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Guan, Yue; Roter, Debra L; Wolff, Jennifer L et al. (2018) The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease. Patient Educ Couns 101:817-823
Li, Jinlei; Ogrodnik, Matthew; Devine, Sherral et al. (2018) Practical risk score for 5-, 10-, and 20-year prediction of dementia in elderly persons: Framingham Heart Study. Alzheimers Dement 14:35-42
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487

Showing the most recent 10 out of 791 publications